Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 66,168 | 67,704 | 105,655 | 125,341 | 320,268 |
| Cost of Goods | 47,357 | 54,717 | 59,560 | 60,065 | 77,725 |
| Gross Profit | 18,811 | 12,987 | 46,095 | 65,276 | 242,543 |
| Operating Expenses | 43,992 | 50,256 | 46,303 | 52,547 | 41,335 |
| Operating Income | -24,824 | -36,552 | 352 | 12,794 | 201,933 |
| Other Income | 3,775 | 3,090 | 1,405 | 958 | 45 |
| Pre-tax Income | -21,049 | -33,462 | 1,757 | 13,752 | 201,978 |
| Income Tax | -5,200 | -9,386 | 414 | 2,653 | 48,421 |
| Net Income Continuous | -15,849 | -24,076 | 1,343 | 11,099 | 153,557 |
| Minority Interests | -509 | -244 | -376 | -438 | -422 |
| Net Income | $-15,340 | $-23,832 | $1,719 | $11,537 | $153,979 |
| EPS Basic Total Ops | -0.52 | -0.77 | 0.06 | 0.38 | 5.09 |
| EPS Basic Continuous Ops | -0.54 | -0.77 | 0.04 | 0.37 | 5.08 |
| EPS Diluted Total Ops | -0.52 | -0.73 | 0.06 | 0.37 | 4.93 |
| EPS Diluted Continuous Ops | -0.54 | -0.73 | 0.04 | 0.36 | 4.92 |
| EBITDA(a) | $-18,423 | $-26,213 | $11,179 | $22,452 | $208,538 |